申请人:Pfizer Inc
公开号:US05627200A1
公开(公告)日:1997-05-06
This invention relates to methods for treating intestinal motility disorders, intestinal ulcerations, including inflammatory bowel disease, ulcerative colitis, Crohn's disease and proctitis, and gastrointestinal ulcerations, depression, prostate disease and dyslipidemia by administering a .beta..sub.3 -adrenoceptor antagonist or agonist.
这项发明涉及通过给予β3-肾上腺素受体拮抗剂或激动剂来治疗肠道运动障碍、肠溃疡(包括炎症性肠病、溃疡性结肠炎、克罗恩病和直肠炎)、胃肠溃疡、抑郁症、前列腺疾病和血脂异常的方法。